ME/CFS Evidence Browser — Classified Studies on Myalgic Encephalomyelitis

261–280 of 280 studies

E3 PreliminaryCohortPEM not requiredCross-Sectional

Secondary structural changes of proteins in fingernails of chronic fatigue syndrome patients from Fourier-transform infrared spectra.

Sakudo, Akikazu, Kuratsune, Hirohiko, Kato, Yukiko Hakariya et al.·Clinica chimica acta; international journal of clinical chemistry·2009

Researchers used a special infrared scanner to examine fingernails from people with ME/CFS and compared them to healthy people's nails. They found that the proteins in ME/CFS patients' nails had different structures—specifically, the nails showed less of a protein structure called alpha-helix and more of a structure called beta-sheet. This suggests that ME/CFS may cause measurable changes in nail composition that could potentially be detected with this scanning technology.

Biomarkers

E3 PreliminaryMechanismPEM not requiredCross-Sectional

Identification of marker genes for differential diagnosis of chronic fatigue syndrome.

Saiki, Takuya, Kawai, Tomoko, Morita, Kyoko et al.·Molecular medicine (Cambridge, Mass.)·2008

This study looked at blood samples from ME/CFS patients and compared the activity of genes between patients and healthy people. Researchers found 9 genes that showed different activity patterns in ME/CFS patients—genes involved in energy production, immune cell function, and protein breakdown. These 9 genes were able to correctly identify ME/CFS patients about 94% of the time, suggesting they could potentially be useful as a biological test to diagnose the condition.

Biomarkers

E3 PreliminaryMechanismPEM not requiredObservational

[Chronic fatigue syndrome and herpesvirus reactivation].

Kondo, Kazuhiro·Nihon rinsho. Japanese journal of clinical medicine·2007

This study looked at whether two common viruses that hide dormant in our bodies (HHV-6 and HHV-7) wake up and become active during fatigue. Researchers found that healthy people shed more HHV-6 in their saliva when tired from work, but ME/CFS patients did not show this pattern. However, HHV-7 did increase in both groups, suggesting these viruses might be useful markers to measure fatigue objectively.

BiomarkersImmune System

E3 PreliminaryDiagnosticPEM not requiredCross-Sectional

[Spectroscopic diagnosis of chronic fatigue syndrome by multivariate analysis of visible and near-infrared spectra].

Sakudo, Akikazu, Kuratsune, Hirohiko, Hakariya, Yukiko et al.·Nihon rinsho. Japanese journal of clinical medicine·2007

Researchers tested whether a special light-based technology called visible and near-infrared spectroscopy could help diagnose ME/CFS by analyzing blood samples and skin. The technique uses different wavelengths of light to detect patterns that might differ between people with ME/CFS and healthy people. Early results showed the method could correctly identify about 70-80% of cases, suggesting this approach might one day offer a quick, non-invasive way to help diagnose the condition.

Biomarkers

E3 PreliminaryMechanismPEM not requiredCross-Sectional

[Identification and application of marker genes for differential diagnosis of chronic fatigue syndrome].

Kawai, Tomoko, Rokutan, Kazuhito·Nihon rinsho. Japanese journal of clinical medicine·2007

This study looked for genetic markers (differences in how genes are expressed) that could help doctors diagnose ME/CFS with a blood test. The researchers identified 9 genes that were expressed differently in ME/CFS patients compared to healthy people, and showed these genes could potentially be used to distinguish ME/CFS from other conditions.

Biomarkers

E3 PreliminaryCohortPEM not requiredCross-Sectional

Chronic fatigue syndrome is accompanied by an IgM-related immune response directed against neopitopes formed by oxidative or nitrosative damage to lipids and proteins.

Maes, Michael, Mihaylova, Ivana, Leunis, Jean-Claude·Neuro endocrinology letters·2006

This study found that people with ME/CFS have higher levels of immune antibodies (IgM) attacking damaged fats and proteins in their bodies. These antibodies target substances created when cells are damaged by oxidative stress—a harmful process where the body's natural defenses become imbalanced. The more severe someone's ME/CFS symptoms were, the higher their antibody levels tended to be.

BiomarkersImmune System

E3 PreliminaryDiagnosticPEM unclearMethods-Paper

CFSUM1 and CFSUM2 in urine from patients with chronic fatigue syndrome are methodological artefacts.

Chalmers, Ronald A, Jones, Mark G, Goodwin, C Stewart et al.·Clinica chimica acta; international journal of clinical chemistry·2006

An earlier study claimed to find two special markers in the urine of ME/CFS patients that could help diagnose the condition. This study re-examined those findings and discovered that these supposed markers were actually just artifacts—unintended byproducts created by the way the urine samples were prepared in the lab, not real biological differences between patients and healthy people.

Biomarkers

E3 PreliminaryMechanismPEM not requiredCross-Sectional

Gene expression profile of empirically delineated classes of unexplained chronic fatigue.

Carmel, Liran, Efroni, Sol, White, Peter D et al.·Pharmacogenomics·2006

Researchers examined genes in blood samples from 111 women with unexplained chronic fatigue to see if different types of fatigue had different gene patterns. They used computer analysis to identify specific genes that were active or inactive in different fatigue groups. They found that certain genes were consistently different between fatigued and healthy people, while other genes only differed in specific fatigue subgroups.

Biomarkers

E3 PreliminaryMechanismPEM not requiredObservational

Exploration of the gene expression correlates of chronic unexplained fatigue using factor analysis.

Fostel, Jennifer, Boneva, Roumiana, Lloyd, Andrew·Pharmacogenomics·2006

Researchers used blood tests and symptom questionnaires to look for biological markers that could help identify ME/CFS. They found that ME/CFS involves multiple symptom patterns (fatigue and mood changes being most prominent) and identified 57 genes whose activity differed between people with severe symptoms and those with mild symptoms. However, no single gene or blood test on its own clearly identifies the disease.

Biomarkers

E3 PreliminaryDiagnosticPEM not requiredMethods-Paper

Interpreter of maladies: redescription mining applied to biomedical data analysis.

Waltman, Peter, Pearlman, Alex, Mishra, Bud·Pharmacogenomics·2006

This paper describes a new computational method for analyzing complex medical data to better understand disease causes. The authors explain how combining genetic, protein, and clinical information from patients and healthy people can reveal hidden patterns that explain why diseases like ME/CFS occur and progress. They demonstrate this approach using a large CDC dataset from patients with ME/CFS.

Biomarkers

E3 PreliminaryCohortPEM unclearCase-Control

A Chronic Fatigue Syndrome - related proteome in human cerebrospinal fluid.

Baraniuk, James N, Casado, Begona, Maibach, Hilda et al.·BMC neurology·2005

Researchers examined fluid from around the spine (cerebrospinal fluid) in people with ME/CFS and found specific proteins that were present in patients but absent in healthy people. Using advanced laboratory techniques, they identified a set of 5 key proteins that could correctly identify ME/CFS in 80% of cases. These findings suggest ME/CFS may involve immune system and brain inflammation, offering hope for an objective test in the future.

NeuroinflammationBiomarkers

E3 PreliminaryMechanismPEM not requiredCross-Sectional

Chronic phase lipids in sera of chronic fatigue syndrome (CFS), chronic ciguatera fish poisoning (CCFP), hepatitis B, and cancer with antigenic epitope resembling ciguatoxin, as assessed with MAb-CTX.

Hokama, Y, Uto, G A, Palafox, N A et al.·Journal of clinical laboratory analysis·2003

Researchers found that people with ME/CFS have unusual lipids (fatty substances) in their blood that react similarly to toxins found in certain poisoned fish. The study tested blood samples from ME/CFS patients and compared them to healthy people and patients with other diseases. About 96% of ME/CFS patients showed high levels of these lipids, suggesting they may be a distinctive feature of the condition.

Biomarkers

E3 PreliminaryCohortPEM not requiredCase-Control

Chronic Fatigue Syndrome (CFS) in 15 dogs and cats with specific biochemical and microbiological anomalies.

Tarello, W·Comparative immunology, microbiology and infectious diseases·2001

This study looked at 15 dogs and cats that had fatigue symptoms similar to ME/CFS and tested their blood for bacterial infections. Nine out of 15 animals had a type of bacteria called Staphylococcus in their blood. When these animals were treated with an antibiotic drug, all of them got completely better and the bacteria disappeared from their blood.

Biomarkers

E3 PreliminaryMechanismPEM not requiredCase-Control

Interferon-induced proteins are elevated in blood samples of patients with chemically or virally induced chronic fatigue syndrome.

Vojdani, A, Lapp, C W·Immunopharmacology and immunotoxicology·1999

This study found that certain immune proteins called 2-5A and PKR are elevated in the blood of ME/CFS patients, whether their illness was triggered by a viral infection or chemical exposure. The researchers discovered that these two triggers activate these proteins through different biological pathways—viruses primarily use an immune signaling molecule called interferon-beta, while chemicals activate them mainly through heat shock proteins.

BiomarkersImmune System

E3 PreliminaryReviewPEM not requiredReview-Narrative

Neuroimaging in chronic fatigue syndrome.

Lange, G, Wang, S, DeLuca, J et al.·The American journal of medicine·1998

This review examines how brain imaging scans can help understand ME/CFS. Researchers looked at two main types of scans: MRI scans that show the structure of the brain, and SPECT scans that show blood flow in the brain. The article discusses what these imaging techniques have revealed so far and what challenges doctors face in using them to diagnose ME/CFS.

Biomarkers

E3 PreliminaryCohortPEM not requiredCross-Sectional

["Prolonged" decay test and auditory brainstem responses in the clinical diagnosis of the chronic fatigue syndrome].

Neri, G, Bianchedi, M, Croce, A et al.·Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale·1996

This study tested whether two hearing-related tests could help diagnose ME/CFS. Researchers examined 21 people with suspected ME/CFS using specialized hearing tests that measure how the brainstem processes sound and how the ear muscles respond to loud noises. When both tests were combined, they correctly identified about 82% of people with ME/CFS, suggesting these tests might be useful diagnostic tools.

Biomarkers

E3 PreliminaryMechanismPEM not requiredObservational

Acylcarnitine deficiency in chronic fatigue syndrome.

Kuratsune, H, Yamaguti, K, Takahashi, M et al.·Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1994

This study found that people with ME/CFS have lower levels of acylcarnitine, a substance that helps muscles produce energy, in their blood. Because acylcarnitine plays an important role in how muscles use energy, this deficiency might explain why ME/CFS patients experience fatigue, muscle pain, and weakness. Importantly, acylcarnitine levels tended to improve as patients recovered, suggesting it could be useful for tracking disease severity.

BiomarkersPost-Exertional Malaise

E3 PreliminaryMechanismPEM not requiredCross-Sectional

Skeletal muscle bioenergetics in the chronic fatigue syndrome.

Barnes, P R, Taylor, D J, Kemp, G J et al.·Journal of neurology, neurosurgery, and psychiatry·1993

Researchers used a special type of MRI scan to measure how muscles use energy in ME/CFS patients compared to healthy people. They found that most patients had normal muscle energy use, but about a quarter showed unusual patterns in how their muscles handled acid buildup during exercise. This suggests muscle metabolism problems may exist in some, but not all, ME/CFS patients.

Biomarkers

E3 PreliminaryCohortPEM unclearCross-Sectional

[Symptoms, signs and laboratory findings in patients with chronic fatigue syndrome].

Kuratsune, H, Yamaguti, K, Hattori, H et al.·Nihon rinsho. Japanese journal of clinical medicine·1992

This study examined 59 patients with ME/CFS to identify common symptoms and laboratory abnormalities. The main findings were that patients experienced prolonged fatigue after exercise, headaches, sleep problems, and mild fevers. Researchers found that ME/CFS patients had low levels of a substance called acylcarnitine in their muscles, which may help explain why their bodies struggle to produce energy and why they experience muscle pain and worsening symptoms after activity.

BiomarkersPost-Exertional Malaise

E3 PreliminaryReviewPEM unclearReview-Narrative

Fatigue syndromes: new thoughts and reinterpretation of previous data.

Downey, D C·Medical hypotheses·1992

This study examined 19 patients with severe fatigue who showed unusual reactions to copper-containing bracelets or necklaces. The researchers found that 8 of these patients had deficiencies in enzymes related to heme (a component of blood), and suggested that problems with copper metabolism and heme processing might explain fatigue in conditions like ME/CFS, multiple sclerosis, and other disorders.

Biomarkers

← Previous

Or browse by topic

PEM Immune Neuro Metabolic Biomarkers Severe ME Long COVID Cognitive

Evidence Atlas

Evidence browser

Secondary structural changes of proteins in fingernails of chronic fatigue syndrome patients from Fourier-transform infrared spectra.

Identification of marker genes for differential diagnosis of chronic fatigue syndrome.

[Chronic fatigue syndrome and herpesvirus reactivation].

[Spectroscopic diagnosis of chronic fatigue syndrome by multivariate analysis of visible and near-infrared spectra].

[Identification and application of marker genes for differential diagnosis of chronic fatigue syndrome].

Chronic fatigue syndrome is accompanied by an IgM-related immune response directed against neopitopes formed by oxidative or nitrosative damage to lipids and proteins.

CFSUM1 and CFSUM2 in urine from patients with chronic fatigue syndrome are methodological artefacts.

Gene expression profile of empirically delineated classes of unexplained chronic fatigue.

Exploration of the gene expression correlates of chronic unexplained fatigue using factor analysis.

Interpreter of maladies: redescription mining applied to biomedical data analysis.

A Chronic Fatigue Syndrome - related proteome in human cerebrospinal fluid.

Chronic phase lipids in sera of chronic fatigue syndrome (CFS), chronic ciguatera fish poisoning (CCFP), hepatitis B, and cancer with antigenic epitope resembling ciguatoxin, as assessed with MAb-CTX.

Chronic Fatigue Syndrome (CFS) in 15 dogs and cats with specific biochemical and microbiological anomalies.

Interferon-induced proteins are elevated in blood samples of patients with chemically or virally induced chronic fatigue syndrome.

Neuroimaging in chronic fatigue syndrome.

["Prolonged" decay test and auditory brainstem responses in the clinical diagnosis of the chronic fatigue syndrome].

Acylcarnitine deficiency in chronic fatigue syndrome.

Skeletal muscle bioenergetics in the chronic fatigue syndrome.

[Symptoms, signs and laboratory findings in patients with chronic fatigue syndrome].

Fatigue syndromes: new thoughts and reinterpretation of previous data.

Curated Collections

Neuroinflammation Evidence

Metabolism & Mitochondria

Biomarkers

PEM-Specific Research